Omobolanle Janet Jesumoroti

Omobolanle Janet Jesumoroti

Auto-generated profile, based on publicly available information

Omobolanle Janet Jesumoroti

Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2018 in MedChemComm
Verified
Journal Article
Closed access
PDF file
OJOmobolanle J. Jesumoroti
Omobolanle J. Jesumoroti
FFFaridoon Faridoon
Faridoon Faridoon
DMDumisani Mnkandhla
Dumisani Mnkandhla
MIMichelle Isaacs
Michelle Isaacs
HHHeinrich Hoppe
Heinrich Hoppe
FAFaridoon
Faridoon
In an attempt to identify potential new agents that are active against HIV-1 IN, a series of novel coumarin-3-carbohydrazide derivatives were designed and synthesised. The toxicity profiles of these compounds showed that they were non-toxic to human cells and they exhibited promising anti-HIV-1 IN activities with IC50 values in nM range. Also, an accompanying molecular modeling study showed that the compounds bind to the active pocket of the enzyme.

1 March 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PDPhelelisiwe Siduduziwe Dube
Phelelisiwe Siduduziwe Dube
LLLesetja J. Legoabe
Lesetja J. Legoabe
AJAudrey Jordaan
Audrey Jordaan
OJOmobolanle J. Jesumoroti
Omobolanle J. Jesumoroti
TTTendamudzimu Tshiwawa
Tendamudzimu Tshiwawa
RBRichard Mbi Beteck
Richard Mbi Beteck

22 May 2022 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
OJOmobolanle Janet Jesumoroti
Omobolanle Janet Jesumoroti
RBRichard Mbi Beteck
Richard Mbi Beteck
AJAudrey Jordaan
Audrey Jordaan
DWDigby Warner
Digby Warner
LLLesetja J. Legoabe
Lesetja J. Legoabe

9 September 2021 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
LPLianie Pieterse
Lianie Pieterse
RBRichard M. Beteck
Richard M. Beteck
BBBlandine Baratte
Blandine Baratte
OJOmobolanle J. Jesumoroti
Omobolanle J. Jesumoroti
TRThomas Robert
Thomas Robert
LLLesetja J. Legoabe
Lesetja J. Legoabe

3 February 2021 in Drug Research
Verified
Journal Article
Closed access
PDF file
OJOmobolanle J. Jesumoroti
Omobolanle J. Jesumoroti
RBRichard M. Beteck
Richard M. Beteck
LLLesetja J. Legoabe
Lesetja J. Legoabe
Sleeping sickness, caused by trypanosomes, is a debilitating, neglected tropical disease wherein current treatments suffer from several drawbacks such as toxicity, low activity, and poor pharmacokinetic properties, and hence the need for alternative treatment is apparent. To this effect, we screened in vitro a library of 2-quinazolinone derivatives for antitrypanosomal activity against T.b. brucei and cytotoxicity against HeLa cells. Seven compounds having no overt cytotoxicity against HeLa cells exhibited antitrypanosomal activity in the range of 0.093–45 µM were identified. The activity data suggests that the antitrypanosomal activity of this compound class is amenable to substituents at N1 and C6 positions. Compound 14 having a molecular weight of 238Da, ClogP value of 1 and a total polar surface area of 49 was identified as the most active, exhibiting an IC50 value of 0.093 µM [Graphical Abstract]. Received: 20 November 2020 Accepted: 05 January 2021 Article published online: 03 February 2021 © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

19 February 2021 in Drug Research
Verified
Journal Article
Closed access
PDF file
OJOmobolanle J. Jesumoroti
Omobolanle J. Jesumoroti
RBRichard M. Beteck
Richard M. Beteck
LLLesetja J. Legoabe
Lesetja J. Legoabe
Omobolanle J. Jesumoroti , Richard M. Beteck, Lesetja J. Legoabe. In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3-4-dihydroquinazolin-2(1H)-one Derivatives. Drug Res 2021 DOI: 10.1055/a-1349-1256 In the above mentioned article the title wasn’t correct. Correct is: In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3-4-dihydroquinazolin-2(1H)-one Derivatives Publication Date: 19 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany